An aberrant activation of IL6/JAK/STAT3 and tofacitinib gene signatures was found in biopsies from SSc patients and Tofacitinib was reported to be effective in preventing bleomycin-induced skin and lung fibrosis in the animal models. Here, STAT3 is linked to systemic sclerosis.